iRhythm Technologies Inc (IRTC)
Pitch Summary: Claims heavy dependence on Zio with reimbursement and competitive pressure makes the model fragile. Flags accounting/quality and disclosure issues that it believes overstate true performance. Concludes the premium valuation is unjustified vs. med-tech peers. BSD Analysis: Spruce Point’s thesis stresses iRhythm’s overdependence on Zio monitors and reimbursement uncertainty. Medicare policies and payer dynamics […]
